Back to Search
Start Over
Hepatitis C virus and type 1 diabetes.
- Source :
-
La Clinica terapeutica [Clin Ter] 2013; Vol. 164 (5), pp. e437-44. - Publication Year :
- 2013
-
Abstract
- Hepatitis C virus infection and diabetes mellitus are two worldwide, major public health problems with increasing complication and mortality rates. Type 1 diabetes mellitus (T1D) is characterized by an autoimmune process leading to pancreatic beta cell destruction; only when the major part of pancreatic beta cells have been destroyed the diabetes become clinically manifest. At the basis of the development of the T1D there is an interplay among environmental factors, pancreatic beta cells, the innate and adaptive immune system, the genetic background and the comorbidities of the patient. Viral infections, including hepatitis C virus infection, may be one of the factors that can almost accelerate progression to diabetes, through different mechanisms.
- Subjects :
- Adjuvants, Immunologic adverse effects
Adjuvants, Immunologic therapeutic use
Antiviral Agents adverse effects
Antiviral Agents therapeutic use
Autoimmune Diseases immunology
Autoimmunity drug effects
Comorbidity
Cytokines metabolism
Cytopathogenic Effect, Viral
Diabetes Mellitus, Type 1 immunology
Disease Susceptibility
Hepatitis C, Chronic drug therapy
Hepatitis C, Chronic virology
Humans
Insulin Resistance
Interferon-alpha adverse effects
Interferon-alpha therapeutic use
Islets of Langerhans immunology
Islets of Langerhans virology
Prediabetic State complications
Prediabetic State immunology
Thyroiditis, Autoimmune etiology
Thyroiditis, Autoimmune immunology
Autoimmune Diseases etiology
Diabetes Mellitus, Type 1 etiology
Hepacivirus pathogenicity
Hepatitis C, Chronic complications
Subjects
Details
- Language :
- English
- ISSN :
- 1972-6007
- Volume :
- 164
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- La Clinica terapeutica
- Publication Type :
- Academic Journal
- Accession number :
- 24217846
- Full Text :
- https://doi.org/10.7417/CT.2013.1624